ANIP
ANI PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$76.14
+0.99%Margins
Gross margin
65.2%
EBITDA margin
26.1%
EBIT margin
15.3%
Net margin
10.8%
FCF margin
16.3%
17.7%
Return on equity
7.1%
Return on assets
16.2%
Return on invested capital
0.67x
Asset turnover
$189.5M
Cash from operations
$16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026